Sharemaestro Newsreel

Simulations Plus, Inc. (SLP) Stock Analysis: Evaluating the Healthcare Software Specialist with 7.5% Revenue Growth

Weave Communications, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:WEAV) 2026-08-07

Key Points Interested in Weave Communications, Inc.? Here are five stocks we like better. Weave reported solid Q2 financial results: Revenue increased 15.5% year over year to $67.5 million, while non-GAAP operating income improved to $3.2 million from breakeven. The company also generated $8.7 …

Privia Health raises 2026 guidance to up to 1.65M attributed lives

Privia Health (PRVA) reported strong Q2 2026 results with revenue up 21.4% to $632.6 million and net income soaring 236.7% to $9.0 million. The company raised its full-year 2026 guidance for GAAP revenue to the high end of $2.35–$2.45 billion and Adjusted EBITDA to …

Mangoceuticals, Inc. (MGRX) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Mangoceuticals, Inc. (MGRX) stock, including its current price, historical data, financial metrics, and company profile. MGRX is engaged in the development and sale of men's wellness products through a telemedicine platform, offering brands like Mango, …

So-Young International (SY) to Release Earnings on Thursday

So-Young International (SY) is set to release its Q2 2026 earnings before the market opens on Thursday, August 13th, with analysts anticipating a loss of $0.0879 per share and revenue of $70.4 million. The company previously exceeded estimates in Q1 2026, reporting a smaller …

HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline

Segall Bryant & Hamill LLC Invests $1.19 Million in OptimizeRx Corp. $OPRX

Segall Bryant & Hamill LLC has invested $1.19 million in OptimizeRx Corp. (NASDAQ: OPRX), acquiring 188,704 shares, which gives them a 1.01% stake in the company. Institutional investors now collectively own 76.47% of OptimizeRx, which recently exceeded quarterly earnings and revenue expectations. Analysts generally …

Health Catalyst (Nasdaq: HCAT) sells Vitalware, ends credit facility debt

Health Catalyst (HCAT) has completed the sale of its Vitalware business to Med-Metrix for $147 million, using the proceeds to fully repay its credit facility debt of $159.9 million. This move is expected to eliminate approximately $19 million in annual interest expenses and will …

Privia Health Group, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PRVA)

Privia Health Group, Inc. (PRVA) published its Q2 2026 earnings call presentation. The company reported an EPS of $0.19, missing estimates by $0.05, but revenue reached $632.63M, beating expectations by $31.87M and representing a 21.39% year-over-year increase. This presentation was released in conjunction with …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Phreesia, Inc. (NYSE:PHR) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to learn more …

PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus

PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 million. Its non-GAAP profit of $0.19 …

Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Nuclea Energy Inc., a merger partner of Mangoceuticals, has signed a Memorandum of Understanding with New Mining Co. to collaborate on the deployment of behind-the-meter modular reactors for high-density computing infrastructure. This partnership aims to provide reliable, carbon-free, and cost-effective power solutions for data …

LifeMD, Inc. Stock 12‑Month Price Target Cut to $9, Implies 145% Upside

LifeMD, Inc.'s average 12-month price target has been reduced from $9.88 to $9 by 8 analysts, with forecasts ranging from $7 to $15 per share. Despite the cut, this new target still suggests a substantial 145% potential upside from its Aug. 5 closing price. …

Doximity, Inc. stock falls to $20.66 despite revenue beat and raised guidance

Omada Health Inc (OMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability ...

Omada Health Inc (OMDA) reported a record-breaking Q2 2026 with $88 million in revenue, up 43% year-over-year, and achieved GAAP net income profitability for the second consecutive quarter. The company saw significant growth in total members and raised its full-year 2026 revenue and adjusted …

Weave Communications, Inc. $WEAV Shares Acquired by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership significantly increased its stake in Weave Communications (NYSE:WEAV) during the first quarter, acquiring an additional 327,721 shares to own a total of 364,240 shares valued at approximately $1.68 million. This move highlights institutional interest in WEAV, with other hedge funds …

Weave Communications (NYSE:WEAV) Issues Quarterly Earnings Results

Health Catalyst (NASDAQ: HCAT) books $151.6M loss and $147M Vitalware sale

Health Catalyst, Inc. (NASDAQ: HCAT) reported a net loss of $151.6 million for the first half of 2026, primarily due to a $122.5 million goodwill impairment charge. The company also announced the sale of its Vitalware business to Med-Metrix for $147 million, with the …

Health Catalyst, Inc. 2026: Revenue $70.49M, EPS ($0.55) — 10-Q Summary

Health Catalyst, Inc. (HCAT) reported Q3 2026 revenue of $70.49 million, a decline from $80.72 million in the prior year, and a net loss of ($0.55) per diluted share. The company attributes the revenue drop to customer churn from DOS-to-Ignite migrations and the exit …

Hinge Health (HNGE) Stock Defies Rich P E On Strong Margins

Hinge Health (HNGE) shares rose 1.7% after strong Q2 2026 results, reporting US$213m revenue, US$62m operating income, and US$100m free cash flow, indicating robust profitability and operating leverage. The company's multi-condition platform strategy, including the migraine program and Cylinder Health acquisition, is showing success …

Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside

Carlsmed, Inc. (CARL) has seen its average 12-month stock price target raised from $18.6 to $19.2 by 5 analysts, with individual forecasts ranging from $17 to $23. This updated target suggests a potential upside of approximately 42% based on the August 5th closing price. …

Spok-Powered Hospitals Recognized on 2026-2027 U.S. News & World Report's Best Hospitals Honor Roll

Spok, Inc. announced that 18 out of 20 hospitals on the 2026-2027 U.S. News & World Report Best Hospitals Honor Roll utilize Spok technology for care coordination. This highlights the continued reliance of leading healthcare systems on Spok's solutions to enhance patient outcomes and …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

Pomerantz LLP is investigating potential claims on behalf of investors of Teladoc Health, Inc. (NYSE: TDOC) concerning alleged securities fraud or unlawful business practices. This investigation follows Teladoc's updated 2026 revenue guidance, which was significantly lowered due to "uncertainties inherent in cash pay and …

Renaissance Technologies LLC Sells 206,400 Shares of Weave Communications, Inc. $WEAV

Renaissance Technologies LLC reduced its stake in Weave Communications, Inc. (NYSE:WEAV) by 12.2% in the first quarter, selling 206,400 shares but still retaining 1.49 million shares valued at approximately $6.87 million. Despite this sale, institutional investors collectively own 86.83% of the stock. Analysts currently …

Privia Health Group Inc (PRVA) Stock Down 8.2% -- Now Undervalued? GF Score: 88/100

Privia Health Group Inc (PRVA) shares fell 8.2% to $22.00, but are considered undervalued by the GF Value™ estimate of $27.63, creating a 20.4% margin of safety. The company has a strong GF Score™ of 88/100, with high ratings for growth and valuation, despite …

Weave Communications (NYSE: WEAV) narrows Q2 loss as revenue rises

Weave Communications (NYSE: WEAV) reported a narrowed Q2 2026 net loss of $4.257 million, down from $8.711 million in Q2 2025, with revenue rising 16% year-over-year to $67.542 million. The vertical SaaS provider, which serves small and medium-sized healthcare practices, saw strong gross margins …

Hinge Health (NYSE: HNGE) posts 212,817 Q2 revenue and net income

Certara, Inc. (NASDAQ:CERT) Given Average Rating of "Hold" by Analysts

Analysts have given Certara, Inc. (NASDAQ:CERT) an average "Hold" rating, with a consensus 12-month price target of $8.95, though several brokerages recently lowered their targets. The company's recent financial results fell short of expectations, reporting quarterly EPS of $0.08 against a $0.09 consensus and …

CareCloud Inc (CCLD) (Q2 2026) Earnings Call Highlights: Strategic Investments Drive Growth ...

CareCloud Inc (CCLD) reported 16% year-over-year revenue growth in Q2 2026, marking its ninth consecutive quarter of positive GAAP net income, driven by strategic investments in AI and key acquisitions. Despite a decrease in GAAP net income and Adjusted EBITDA due to these investments …

Press Release: Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst has announced the completion of the sale of its Vitalware business to RLDatix. This strategic move allows Health Catalyst to sharpen its focus on its core healthcare intelligence and analytics offerings, streamlining its operations and strengthening its balance sheet. The company anticipates …

Earnings call transcript: Omada Health posts Q2 2026 profit beat, lifts guidance

Omada Health reported a strong Q2 2026, exceeding profit forecasts and raising its full-year guidance due to robust demand for its chronic disease management platform. The company achieved its second consecutive quarter of GAAP profitability, with significant growth in revenue and adjusted EBITDA, driven …

Schrödinger (SDGR) Stock Rallies On Profit Turn But Durability Questions Remain

Earnings call transcript: Health Catalyst posts Q2 2026 revenue beat, shares sink

Health Catalyst (HCAT) reported Q2 2026 revenue above Wall Street expectations, reaching $70.5 million, and adjusted EBITDA at the high end of guidance. However, the company's shares sank by over 27% in after-hours trading due to a weaker full-year outlook, which was primarily impacted …

10x Genomics’s (NASDAQ:TXG) Q2 CY2026: Strong Sales, Full-Year Outlook Slightly Exceeds Expectations

Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

10x Genomics (NASDAQ: TXG) grows consumables, ends Q2 with $502M cash

10x Genomics reported a Q2 2026 total revenue of $151.0M, a 13% decrease from Q2 2025, primarily due to the absence of large, non-recurring patent-license settlements from the previous year. Despite this, underlying products and services revenue grew by 3% to $149.1M, driven by …